CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?
about
Head mass in chronic pancreatitis: Inflammatory or malignantModeling prognostic factors in resectable pancreatic adenocarcinomas.Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancerMicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.Utility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic headDiagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses.The Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of PancreasPredictors of malignancy in chronic calcific pancreatitis with head mass.Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.Imaging of focal autoimmune pancreatitis and differentiating it from pancreatic cancer.Pancreatic cancer in chronic pancreatitis.Predictors of malignancy in pancreatic head mass: a prospective study.Preoperative Platelet-Lymphocyte Ratio Augments CA 19-9 as a Predictor of Malignancy in Chronic Calcific Pancreatitis.Etiology, pathology, management and prognosis of chronic pancreatitis in Chinese population: A retrospective study.Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.Autoimmune pancreatitis misdiagnosed as a tumor of the head of the pancreas.The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.[Chronic pancreatitis or pancreatic malignancy: clinical and radiological differential diagnosis of pancreas head space-occupying mass].Prevention of Renal Scarring in Acute Pyelonephritis by Probiotic Therapy: an Experimental Study.Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis.Serum Level of Ca 19-9 Increases Ability of IgG4 Test to Distinguish Patients with Autoimmune Pancreatitis from Those with Pancreatic Carcinoma
P2860
Q27011806-6A8A76B6-D71D-451C-BB42-B72ED6D5C632Q33831911-A23538A2-2C4F-4ACE-A4E3-879BC45452B2Q34577084-CA66B632-3513-431F-9C58-2F887E7FB398Q34704824-62A34F46-8BBD-4EAF-9AB6-1E2514F5BDDCQ35375731-6097CDA7-C439-4F26-982A-0FCD5889F9B3Q36025215-976BBFC6-2983-4A82-8528-AF82E6D5B520Q36192092-E681F065-196E-4B8B-AFA9-1A4A5D6C4527Q36648293-AFE8F4EA-B768-4976-91BB-9EAED8C6503DQ36831137-3D57EBC6-D463-4964-BE91-34BC99A8AC1EQ36876415-FD488CCF-CB78-4892-AB64-716C79A97BDCQ38018315-962D76B4-21F6-41D2-ABB9-D9C8C6FCDE67Q38021384-EC48C110-C864-42E8-A52C-E329C96E9A33Q38115619-A8E83C04-6254-4AEE-B903-8D8920276D66Q38223426-FCD83B67-128E-4501-B7F3-FA7686585F04Q38971873-188C861A-D84D-49EA-9BFD-6277C0829E27Q39091616-60088CA1-B5F0-4858-BA6F-AB49DFE9DA5BQ39381682-0767B9C9-E2C8-4297-B09B-AEC14B8D7DB2Q40838221-F2E57D83-CA28-481B-97B1-1F568F3E4F06Q40975840-48A819D7-8E7E-4140-A6B5-46BA64194BA6Q42108592-7F4BA86F-E304-48C1-B369-AB0AF48ED6ADQ42238114-A7F0EF91-1A6B-4440-B576-4BF254552F0FQ44510206-3EA7CBD9-8950-4B79-89B3-ADDC81A669F0Q47284581-DFE575D4-72FA-49E8-961A-C944F6F57391Q50060416-FC598EC4-406E-426A-99A2-22781B8C5A27Q58376599-90160987-9940-417D-AC18-9818E964A0A0
P2860
CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@en
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@nl
type
label
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@en
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@nl
prefLabel
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@en
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@nl
P2093
P1476
CA 19-9 to differentiate benig ...... eatitis: is there any benefit?
@en
P2093
P2888
P356
10.1007/S12664-009-0005-4
P407
P577
2009-01-01T00:00:00Z